Does Facebook Lead Young Women to Dangerous Diets?

MONDAY, July 27, 2015 (HealthDay News) -- A new study provides insight into how Facebook use by young women can lead to poor body image and risky dieting.

Drug Makers May Delay Reporting Patient Harms to FDA: Study

MONDAY, July 27, 2015 (HealthDay News) -- Drug companies may be endangering the lives of patients by not promptly reporting cases of drug-related illness or death to federal regulators, a new report suggests.

Praluent Approved to Treat High Cholesterol

MONDAY, July 27, 2015 (HealthDay News) -- Praluent (alirocumab) injection has been approved by the U.S. Food and Drug Administration to treat people with inherited high cholesterol (heterozygous familial hypercholesterolemia) or people at risk of heart attack or stroke from high cholesterol derived from foods or produced by the liver.

Health Tip: When Heel Pain is Afoot

(HealthDay News) -- Pain in the heel may range from a minor nuisance to disabling.

School's Out, Fattening Behaviors Are In

SUNDAY, July 26, 2015 (HealthDay News) -- Your kids probably will eat more sugar, watch more TV and eat fewer vegetables over summer vacation, a new study finds.

FDA OKs First of New Class of Cholesterol Drugs

FRIDAY, July 24, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved Praluent, the first of a powerful new class of injected, cholesterol-lowering drugs that experts believe could change cardiovascular care.

New Skin Cancer Drug Approved by FDA

FRIDAY, July 24, 2015 (HealthDay News) -- A new drug to treat the most common form of skin cancer has been approved by the U.S. Food and Drug Administration.

Technivie Approved for Hepatitis C

FRIDAY, July 24, 2015 (HealthDay News) -- Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without poor liver function (cirrhosis) and without scarring.

Odomzo Approved for Recurring Basal Cell Carcinoma

FRIDAY, July 24, 2015 (HealthDay News) -- Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation.

FDA Wants to Strengthen Sugar Labeling

FRIDAY, July 24, 2015 (HealthDay News) -- The U.S. Food and Drug Administration said Friday it wants food labels to include more information about how much added sugar is in a product, so consumers can see more clearly how much extra sugar they are consuming every day.